Stay updated with breaking news from Nasdaq Vcel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vericel (NASDAQ:VCEL – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings. Analyst Recommendations This is a breakdown of recent ratings […]
Louisiana State Employees Retirement System bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 23,900 shares of the biotechnology company’s stock, valued at approximately $851,000. Louisiana State Employees Retirement System owned 0.05% of Vericel […]
CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe...
Truist Financial reissued their buy rating on shares of Vericel (NASDAQ:VCEL – Free Report) in a research note released on Tuesday, Benzinga reports. The firm currently has a $54.00 price target on the biotechnology company’s stock. Other equities analysts also recently issued research reports about the company. HC Wainwright upped their price objective on Vericel […]
Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0...